Press Release Distribution
The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older.…
For Immediate Release: June 29, 2020 Español Today, the U.S. Food and Drug Administration approved Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf—for injection under the skin to treat adult patients…
For Immediate Release: June 29, 2020 Español Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic…
Spanish Tobacco use is the leading preventable cause of death in the United States, resulting in more than 480,000 deaths annually. Almost 70 percent of current smokers report wanting to…
Consumer articles about medical devices. Source: FDA Technical support by Asia Press Release
Image Español “FDA approved!” Maybe you saw those words on a company’s website, or in a commercial promoting a new product or treatment. Some marketers may say their products are…
Image Español Patient safety is the FDA’s top priority. The U.S. Food and Drug Administration is investigating several potentially cancer-causing substances, called nitrosamines, recently found in some drugs, including those…
Español Your family’s beloved “Fluffy” has gotten sick after eating a certain food, and neither you nor your veterinarian is sure if that food, or something else, is the cause.…